Fairvalue-Calculator Fairvalue-Calculator
EN DE

Excelsior Medical Co (4104) Fair Value & Analysis

Healthcare · TW · Market cap 13.1B TWD

Price68.80 TWD
Fair Value62.93 TWD
Upside-8.5%
Quality80/100
Evidence: Medium Range 41.88 TWD – 99.83 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Excelsior Medical Co (4104) currently trades at 68.80 TWD, while our model-based Fair Value estimate is 62.93 TWD — implying the stock looks roughly 8.5% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in the sale, maintenance, and lease of laser medical equipment for beauty treatment; sale of lifestyle and medical beauty products, cosmetic health care products, precision instruments, and real estate; manufacture of medical equipment; provision of logistics and medical management consultancy services; and investment businesses. The company was formerly known as Enfield Medical Co. Ltd. and changed its name to Excelsior Medical Co., Ltd. in July 2009. Excelsior Medical Co., Ltd. was incorporated in 1988 and is headquartered in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -81% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -38% Sigma Healthcare Limited (SIGGF) -73% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +183%

Frequently asked questions

Is Excelsior Medical Co (4104) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 62.93 TWD versus a price of 68.80 TWD — about −9% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 4104?
Our 21-model fair value for Excelsior Medical Co is 62.93 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 68.80 TWD.
What is the quality score of 4104?
Excelsior Medical Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.